Sign in

CIK 0001761918 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Erasca, Inc.

Sign in to watch
Ticker
ERAS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831217027
Phone
(858) 465-6511
Business address
3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Planned sale Chief Legal Officer sold 80,000 shares at $16.40 ($1,312,000)
  10. 4 Planned sale Chief Medical Officer sold 20,000 shares at $15.04 ($300,760)
  11. 4 Derivatives Options or other derivatives
  12. 4 Other acquisition CFO and CBO acquired 17,793 shares (other)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Planned sale General Counsel & Corp. Sec. sold 120,000 shares at $5.59 ($670,812)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 7 · 127 filings